
At a Glance
Health Technology Holding (HTH) is a venture capital firm with Michelle Gaiotto among its key partners, though detailed information about the firm's founding and specific focus remains limited. Despite the firm's name suggesting a healthcare technology focus, available data indicates HTH invests across a broader range of sectors including aerospace & defense, consumer technology, fintech, and climate tech.
The firm appears to take a stage-agnostic approach, investing from pre-seed through Series B+ rounds, suggesting they work with companies throughout their early growth phases. However, without more detailed portfolio information or specific investment examples, the firm's distinctive investment thesis and market positioning remain unclear. HTH represents one of many venture firms operating with a diversified sector approach rather than deep specialization in a particular vertical.
Health Technology Holding (HTH) primarily invests at the Pre-Seed, Seed, Series A, Series B+ stages. This means they focus on companies that are at the earliest idea or prototype phase.
Health Technology Holding (HTH) focuses on investments in Aerospace & Defense, Other, Consumer, Fintech, Climate. Their portfolio reflects deep expertise and networks within these sectors.
Health Technology Holding (HTH)'s typical investment check size ranges from $500K to $1M. Actual amounts may vary based on the stage, sector, and specific opportunity.